LIVING AFTER CANCER

I just read the Parade insert in the Dallas Morning News while I was visiting Dallas on Monday, 6/21/10. It featured an article “Living After Cancer”, and it dealt with the side-effects of conventional cancer therapy and how they affected post-treatment life. All of this is very alien to those of us who have gone through IPT (IPTLD), as there are little or no side-effects with this kind, gentle, yet effective targeted lowdose chemotherapy.

Just in case you are unfamiliar, too, here is some information on the side-effects they reported.
• Fatigue: can persist in survivors for years
• Pain: neuropathic pain can be caused by some forms of chemotherapy. Radiation and surgery may also leave the patient with scar tissue, leading to painful tightening of the skin’s surface or internal adhesions.
• Cognitive impairment: A most common complaint during and after treatment is “chemo brain”.
• Infertility and sexual dysfunction: Cancer treatment can leave many patients infertile or reporting sexual dysfunction.
• Depression and anxiety: “cancer may leave your body, but it never leaves your mind”.
• Other cancers: 25% of survivors end up having multiple cancers, entirely different cancers from the original. To me, this makes perfect sense when you consider that conventional therapy (surgery, chemo, radiation) has been proven to:
o Weaken the immune system
o Damage vital body organs
o Destroy the P53 tumor-suppressor gene
o Stimulate the cancer
o Cause the cancer to build immunities against the treatments
After all of that, how could the body and the immune system prevent cancer from returning in as many ways as possible?

That is what Best Answer for Cancer is all about: getting the information out about different options that patients have for their care. We believe the best answer for cancer is A solid holistic and integrated platform of healing and strengthening components (mind/body, spirituality, diet/nutrition, detox, immune system boosting, lifestyle and exercise) that supports and strengthens the patient’s body to further increase the effectiveness of a targeted cancer therapy. Our targeted therapy of choice is Insulin Potentiation Targeted LowDose Therapy (IPTLD).